Table of Contents Executive Summary 1 Industry Overview of Pulmonary Arterial Hypertension (PAH) 1.1 Definition of Pulmonary Arterial Hypertension (PAH) 1.2 Pulmonary Arterial Hypertension (PAH) Segment by Type 1.2.1 Global Pulmonary Arterial Hypertension (PAH) Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Prostacyclin and Prostacyclin Analogs 1.2.3 SGC Stimulators 1.2.4 ERA 1.2.5 PDE-5 1.3 Pulmonary Arterial Hypertension (PAH) Segment by Applications 1.3.1 Global Pulmonary Arterial Hypertension (PAH) Consumption Comparison by Applications (2014-2025) 1.3.2 Hospital 1.3.3 Clinic 1.4 Global Pulmonary Arterial Hypertension (PAH) Overall Market 1.4.1 Global Pulmonary Arterial Hypertension (PAH) Revenue (2014-2025) 1.4.2 Global Pulmonary Arterial Hypertension (PAH) Production (2014-2025) 1.4.3 North America Pulmonary Arterial Hypertension (PAH) Status and Prospect (2014-2025) 1.4.4 Europe Pulmonary Arterial Hypertension (PAH) Status and Prospect (2014-2025) 1.4.5 China Pulmonary Arterial Hypertension (PAH) Status and Prospect (2014-2025) 1.4.6 Japan Pulmonary Arterial Hypertension (PAH) Status and Prospect (2014-2025) 1.4.7 Southeast Asia Pulmonary Arterial Hypertension (PAH) Status and Prospect (2014-2025) 1.4.8 India Pulmonary Arterial Hypertension (PAH) Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Pulmonary Arterial Hypertension (PAH) 2.3 Manufacturing Process Analysis of Pulmonary Arterial Hypertension (PAH) 2.4 Industry Chain Structure of Pulmonary Arterial Hypertension (PAH) 3 Development and Manufacturing Plants Analysis of Pulmonary Arterial Hypertension (PAH) 3.1 Capacity and Commercial Production Date 3.2 Global Pulmonary Arterial Hypertension (PAH) Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Pulmonary Arterial Hypertension (PAH) 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Pulmonary Arterial Hypertension (PAH) Production and Capacity Analysis 4.2 Pulmonary Arterial Hypertension (PAH) Revenue Analysis 4.3 Pulmonary Arterial Hypertension (PAH) Price Analysis 4.4 Market Concentration Degree 5 Pulmonary Arterial Hypertension (PAH) Regional Market Analysis 5.1 Pulmonary Arterial Hypertension (PAH) Production by Regions 5.1.1 Global Pulmonary Arterial Hypertension (PAH) Production by Regions 5.1.2 Global Pulmonary Arterial Hypertension (PAH) Revenue by Regions 5.2 Pulmonary Arterial Hypertension (PAH) Consumption by Regions 5.3 North America Pulmonary Arterial Hypertension (PAH) Market Analysis 5.3.1 North America Pulmonary Arterial Hypertension (PAH) Production 5.3.2 North America Pulmonary Arterial Hypertension (PAH) Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Pulmonary Arterial Hypertension (PAH) Import and Export 5.4 Europe Pulmonary Arterial Hypertension (PAH) Market Analysis 5.4.1 Europe Pulmonary Arterial Hypertension (PAH) Production 5.4.2 Europe Pulmonary Arterial Hypertension (PAH) Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Pulmonary Arterial Hypertension (PAH) Import and Export 5.5 China Pulmonary Arterial Hypertension (PAH) Market Analysis 5.5.1 China Pulmonary Arterial Hypertension (PAH) Production 5.5.2 China Pulmonary Arterial Hypertension (PAH) Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Pulmonary Arterial Hypertension (PAH) Import and Export 5.6 Japan Pulmonary Arterial Hypertension (PAH) Market Analysis 5.6.1 Japan Pulmonary Arterial Hypertension (PAH) Production 5.6.2 Japan Pulmonary Arterial Hypertension (PAH) Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Pulmonary Arterial Hypertension (PAH) Import and Export 5.7 Southeast Asia Pulmonary Arterial Hypertension (PAH) Market Analysis 5.7.1 Southeast Asia Pulmonary Arterial Hypertension (PAH) Production 5.7.2 Southeast Asia Pulmonary Arterial Hypertension (PAH) Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Pulmonary Arterial Hypertension (PAH) Import and Export 5.8 India Pulmonary Arterial Hypertension (PAH) Market Analysis 5.8.1 India Pulmonary Arterial Hypertension (PAH) Production 5.8.2 India Pulmonary Arterial Hypertension (PAH) Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Pulmonary Arterial Hypertension (PAH) Import and Export 6 Pulmonary Arterial Hypertension (PAH) Segment Market Analysis (by Type) 6.1 Global Pulmonary Arterial Hypertension (PAH) Production by Type 6.2 Global Pulmonary Arterial Hypertension (PAH) Revenue by Type 6.3 Pulmonary Arterial Hypertension (PAH) Price by Type 7 Pulmonary Arterial Hypertension (PAH) Segment Market Analysis (by Application) 7.1 Global Pulmonary Arterial Hypertension (PAH) Consumption by Application 7.2 Global Pulmonary Arterial Hypertension (PAH) Consumption Market Share by Application (2014-2019) 8 Pulmonary Arterial Hypertension (PAH) Major Manufacturers Analysis 8.1 Actelion 8.1.1 Actelion Pulmonary Arterial Hypertension (PAH) Production Sites and Area Served 8.1.2 Actelion Product Introduction, Application and Specification 8.1.3 Actelion Pulmonary Arterial Hypertension (PAH) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Gilead Sciences 8.2.1 Gilead Sciences Pulmonary Arterial Hypertension (PAH) Production Sites and Area Served 8.2.2 Gilead Sciences Product Introduction, Application and Specification 8.2.3 Gilead Sciences Pulmonary Arterial Hypertension (PAH) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 United Therapeutics 8.3.1 United Therapeutics Pulmonary Arterial Hypertension (PAH) Production Sites and Area Served 8.3.2 United Therapeutics Product Introduction, Application and Specification 8.3.3 United Therapeutics Pulmonary Arterial Hypertension (PAH) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 GlaxoSmithKline 8.4.1 GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Production Sites and Area Served 8.4.2 GlaxoSmithKline Product Introduction, Application and Specification 8.4.3 GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Pfizer 8.5.1 Pfizer Pulmonary Arterial Hypertension (PAH) Production Sites and Area Served 8.5.2 Pfizer Product Introduction, Application and Specification 8.5.3 Pfizer Pulmonary Arterial Hypertension (PAH) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 Bayer 8.6.1 Bayer Pulmonary Arterial Hypertension (PAH) Production Sites and Area Served 8.6.2 Bayer Product Introduction, Application and Specification 8.6.3 Bayer Pulmonary Arterial Hypertension (PAH) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 Arena 8.7.1 Arena Pulmonary Arterial Hypertension (PAH) Production Sites and Area Served 8.7.2 Arena Product Introduction, Application and Specification 8.7.3 Arena Pulmonary Arterial Hypertension (PAH) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 9 Development Trend of Analysis of Pulmonary Arterial Hypertension (PAH) Market 9.1 Global Pulmonary Arterial Hypertension (PAH) Market Trend Analysis 9.1.1 Global Pulmonary Arterial Hypertension (PAH) Market Size (Volume and Value) Forecast 2019-2025 9.2 Pulmonary Arterial Hypertension (PAH) Regional Market Trend 9.2.1 North America Pulmonary Arterial Hypertension (PAH) Forecast 2019-2025 9.2.2 Europe Pulmonary Arterial Hypertension (PAH) Forecast 2019-2025 9.2.3 China Pulmonary Arterial Hypertension (PAH) Forecast 2019-2025 9.2.4 Japan Pulmonary Arterial Hypertension (PAH) Forecast 2019-2025 9.2.5 Southeast Asia Pulmonary Arterial Hypertension (PAH) Forecast 2019-2025 9.2.6 India Pulmonary Arterial Hypertension (PAH) Forecast 2019-2025 9.3 Pulmonary Arterial Hypertension (PAH) Market Trend (Product Type) 9.4 Pulmonary Arterial Hypertension (PAH) Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Pulmonary Arterial Hypertension (PAH) Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Pulmonary Arterial Hypertension (PAH) Table Global Pulmonary Arterial Hypertension (PAH) Production (K Units) Growth Rate Comparison by Types (2014-2025) Figure Global Pulmonary Arterial Hypertension (PAH) Production Market Share by Types in 2018 Figure Prostacyclin and Prostacyclin Analogs Product Picture Figure SGC Stimulators Product Picture Figure ERA Product Picture Figure PDE-5 Product Picture Table Global Pulmonary Arterial Hypertension (PAH) Consumption (K Units) Comparison by Applications (2014-2025) Figure Global Pulmonary Arterial Hypertension (PAH) Consumption Market Share by Applications in 2018 Figure Hospital Figure Clinic Figure Global Pulmonary Arterial Hypertension (PAH) Revenue (Million USD) (2014-2025) Figure Global Pulmonary Arterial Hypertension (PAH) Production (K Units) (2014-2025) Figure North America Pulmonary Arterial Hypertension (PAH) Market Size (Million USD) (2014-2025) Figure Europe Pulmonary Arterial Hypertension (PAH) Market Size (Million USD) (2014-2025) Figure China Pulmonary Arterial Hypertension (PAH) Market Size (Million USD) (2014-2025) Figure Japan Pulmonary Arterial Hypertension (PAH) Market Size (Million USD) (2014-2025) Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Market Size (Million USD) (2014-2025) Figure India Pulmonary Arterial Hypertension (PAH) Market Size (Million USD) (2014-2025) Table Pulmonary Arterial Hypertension (PAH) Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Pulmonary Arterial Hypertension (PAH) in 2018 Figure Manufacturing Process Analysis of Pulmonary Arterial Hypertension (PAH) Figure Industry Chain Structure of Pulmonary Arterial Hypertension (PAH) Table Capacity and Commercial Production Date of Key Manufacturers Table Global Pulmonary Arterial Hypertension (PAH) Manufacturing Plants Distribution Table Pulmonary Arterial Hypertension (PAH) Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Pulmonary Arterial Hypertension (PAH) Capacity (K Units) of Major Manufacturers (2014-2019) Table Pulmonary Arterial Hypertension (PAH) Production (K Units) of Major Manufacturers (2014-2019) Table Pulmonary Arterial Hypertension (PAH) Production Market Share of Major Manufacturers (2014-2019) Figure Pulmonary Arterial Hypertension (PAH) Production Share by Manufacturers in 2018 Table Pulmonary Arterial Hypertension (PAH) Revenue (Million US$) of Major Manufacturers (2014-2019) Table Pulmonary Arterial Hypertension (PAH) Revenue Market Share of Major Manufacturers (2014-2019) Figure Pulmonary Arterial Hypertension (PAH) Revenue Share by Manufacturers in 2018 Table Pulmonary Arterial Hypertension (PAH) Average Price (USD/Unit) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Pulmonary Arterial Hypertension (PAH) Production by Regions 2014-2019 (K Units) Table Global Pulmonary Arterial Hypertension (PAH) Production Market Share by Regions 2014-2019 Figure Global Pulmonary Arterial Hypertension (PAH) Production Market Share by Regions in 2018 Table Global Pulmonary Arterial Hypertension (PAH) Revenue by Regions 2014-2019 (Million USD) Table Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share by Regions 2014-2019 Figure Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share by Regions in 2018 Table Global Pulmonary Arterial Hypertension (PAH) Consumption by Regions 2014-2019 (K Units) Table Global Pulmonary Arterial Hypertension (PAH) Consumption Market Share by Regions 2014-2019 Figure North America Pulmonary Arterial Hypertension (PAH) Production Growth Rate 2014-2019 (K Units) Figure North America Pulmonary Arterial Hypertension (PAH) Revenue Growth Rate 2014-2019 (Million USD) Table North America Pulmonary Arterial Hypertension (PAH) Production, Consumption Import and Export (K Units) Figure Europe Pulmonary Arterial Hypertension (PAH) Production Growth Rate 2014-2019 (K Units) Figure Europe Pulmonary Arterial Hypertension (PAH) Revenue Growth Rate 2014-2019 (Million USD) Table Europe Pulmonary Arterial Hypertension (PAH) Production, Consumption Import and Export (K Units) Figure China Pulmonary Arterial Hypertension (PAH) Production Growth Rate 2014-2019 (K Units) Figure China Pulmonary Arterial Hypertension (PAH) Revenue Growth Rate 2014-2019 (Million USD) Table China Pulmonary Arterial Hypertension (PAH) Production, Consumption Import and Export (K Units) Figure Japan Pulmonary Arterial Hypertension (PAH) Production Growth Rate 2014-2019 (K Units) Figure Japan Pulmonary Arterial Hypertension (PAH) Revenue Growth Rate 2014-2019 (Million USD) Table Japan Pulmonary Arterial Hypertension (PAH) Production, Consumption Import and Export (K Units) Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Production Growth Rate 2014-2019 (K Units) Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Pulmonary Arterial Hypertension (PAH) Production, Consumption Import and Export (K Units) Figure India Pulmonary Arterial Hypertension (PAH) Production Growth Rate 2014-2019 (K Units) Figure India Pulmonary Arterial Hypertension (PAH) Revenue Growth Rate 2014-2019 (Million USD) Table India Pulmonary Arterial Hypertension (PAH) Production, Consumption Import and Export (K Units) Figure Global Consumption Pulmonary Arterial Hypertension (PAH) Market Share by Application (2014-2019) Figure Global Value (Consumption) Pulmonary Arterial Hypertension (PAH) Market Share by Application (2014-2019) Table Actelion Pulmonary Arterial Hypertension (PAH) Production Sites and Area Served Table Actelion Pulmonary Arterial Hypertension (PAH) Product Introduction, Application and Specification Table Actelion Pulmonary Arterial Hypertension (PAH) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Actelion Pulmonary Arterial Hypertension (PAH) Production Growth Rate (2014-2019) Table Actelion Pulmonary Arterial Hypertension (PAH) Production Market Share (2014-2019) Figure Actelion Pulmonary Arterial Hypertension (PAH) Revenue Market Share (2014-2019) Table Actelion Pulmonary Arterial Hypertension (PAH) Main Business and Markets Served Table Gilead Sciences Pulmonary Arterial Hypertension (PAH) Production Sites and Area Served Table Gilead Sciences Pulmonary Arterial Hypertension (PAH) Product Introduction, Application and Specification Table Gilead Sciences Pulmonary Arterial Hypertension (PAH) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Gilead Sciences Pulmonary Arterial Hypertension (PAH) Production Growth Rate (2014-2019) Table Gilead Sciences Pulmonary Arterial Hypertension (PAH) Production Market Share (2014-2019) Figure Gilead Sciences Pulmonary Arterial Hypertension (PAH) Revenue Market Share (2014-2019) Table Gilead Sciences Pulmonary Arterial Hypertension (PAH) Main Business and Markets Served Table United Therapeutics Pulmonary Arterial Hypertension (PAH) Production Sites and Area Served Table United Therapeutics Pulmonary Arterial Hypertension (PAH) Product Introduction, Application and Specification Table United Therapeutics Pulmonary Arterial Hypertension (PAH) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table United Therapeutics Pulmonary Arterial Hypertension (PAH) Production Growth Rate (2014-2019) Table United Therapeutics Pulmonary Arterial Hypertension (PAH) Production Market Share (2014-2019) Figure United Therapeutics Pulmonary Arterial Hypertension (PAH) Revenue Market Share (2014-2019) Table United Therapeutics Pulmonary Arterial Hypertension (PAH) Main Business and Markets Served Table GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Production Sites and Area Served Table GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Product Introduction, Application and Specification Table GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Production Growth Rate (2014-2019) Table GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Production Market Share (2014-2019) Figure GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Revenue Market Share (2014-2019) Table GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Main Business and Markets Served Table Pfizer Pulmonary Arterial Hypertension (PAH) Production Sites and Area Served Table Pfizer Pulmonary Arterial Hypertension (PAH) Product Introduction, Application and Specification Table Pfizer Pulmonary Arterial Hypertension (PAH) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Pfizer Pulmonary Arterial Hypertension (PAH) Production Growth Rate (2014-2019) Table Pfizer Pulmonary Arterial Hypertension (PAH) Production Market Share (2014-2019) Figure Pfizer Pulmonary Arterial Hypertension (PAH) Revenue Market Share (2014-2019) Table Pfizer Pulmonary Arterial Hypertension (PAH) Main Business and Markets Served Table Bayer Pulmonary Arterial Hypertension (PAH) Production Sites and Area Served Table Bayer Pulmonary Arterial Hypertension (PAH) Product Introduction, Application and Specification Table Bayer Pulmonary Arterial Hypertension (PAH) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Bayer Pulmonary Arterial Hypertension (PAH) Production Growth Rate (2014-2019) Table Bayer Pulmonary Arterial Hypertension (PAH) Production Market Share (2014-2019) Figure Bayer Pulmonary Arterial Hypertension (PAH) Revenue Market Share (2014-2019) Table Bayer Pulmonary Arterial Hypertension (PAH) Main Business and Markets Served Table Arena Pulmonary Arterial Hypertension (PAH) Production Sites and Area Served Table Arena Pulmonary Arterial Hypertension (PAH) Product Introduction, Application and Specification Table Arena Pulmonary Arterial Hypertension (PAH) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Arena Pulmonary Arterial Hypertension (PAH) Production Growth Rate (2014-2019) Table Arena Pulmonary Arterial Hypertension (PAH) Production Market Share (2014-2019) Figure Arena Pulmonary Arterial Hypertension (PAH) Revenue Market Share (2014-2019) Table Arena Pulmonary Arterial Hypertension (PAH) Main Business and Markets Served Figure Global Pulmonary Arterial Hypertension (PAH) Production (K Units) Growth Rate Forecast 2019-2025 Figure Global Pulmonary Arterial Hypertension (PAH) Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Pulmonary Arterial Hypertension (PAH) Sales Price (USD/Unit) Forecast 2019-2025 Figure North America Pulmonary Arterial Hypertension (PAH) Production Growth Rate Forecast 2019-2025 (K Units) Figure North America Pulmonary Arterial Hypertension (PAH) Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Pulmonary Arterial Hypertension (PAH) Production Growth Rate Forecast 2019-2025 (K Units) Figure Europe Pulmonary Arterial Hypertension (PAH) Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Pulmonary Arterial Hypertension (PAH) Production Growth Rate Forecast 2019-2025 (K Units) Figure China Pulmonary Arterial Hypertension (PAH) Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Pulmonary Arterial Hypertension (PAH) Production Growth Rate Forecast 2019-2025 (K Units) Figure Japan Pulmonary Arterial Hypertension (PAH) Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Production Growth Rate Forecast 2019-2025 (K Units) Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Pulmonary Arterial Hypertension (PAH) Production Growth Rate Forecast 2019-2025 (K Units) Figure India Pulmonary Arterial Hypertension (PAH) Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Units) of Pulmonary Arterial Hypertension (PAH) by Type (2019-2025) Table Global Consumption (K Units) of Pulmonary Arterial Hypertension (PAH) by Application (2019-2025) Table Pulmonary Arterial Hypertension (PAH) Distributors List Table Pulmonary Arterial Hypertension (PAH) Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Actelion Gilead Sciences United Therapeutics GlaxoSmithKline Pfizer Bayer Arena